News

21/07/14
Stallergenes expands Latin American presence with acquisition of ALERGO PHARMA S.R.L. in Argentina

Antony (France), 21 July 2014 – STALLERGENES, a global healthcare company...

[more]
08/07/14
Stallergenes welcomes Fleur Pellerin, Secretary of State for Foreign Trade to its principal site in Antony, Hauts-de-Seine, France.

Antony, France, 8 July 2014 – STALLERGENES S.A. (Euronext Paris), a global...

[more]

Follow us on :

STALLERGENES, A GLOBAL ALLERGY PLAYER


Stallergenes is a global pharmaceutical company with leading innovation, provider of allergy solutions all around the world. 

Stallergenes has a comprehensive approach of the allergic diseases with a complete portfolio combining diagnosis products and treatments and has brought the new generation of allergen immunotherapy treatments.